FDA Inspection 1075000 — Joseph R. Holtman, Jr., M.D., Ph.D.
The FDA completed an inspection of Joseph R. Holtman, Jr., M.D., Ph.D. on Nov 9, 2018 in Maywood, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 9, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Maywood, IL (United States)
Additional Details
Sponsor-Investigator (S-I)